Literature DB >> 2710169

Structural alterations of chromosome 2 in Leishmania major as evidence for diploidy, including spontaneous amplification of the mini-exon array.

D M Iovannisci1, S M Beverley.   

Abstract

We have utilized pulsed field electrophoresis to characterize several karyotypic alterations in Leishmania major. Promastigotes of the LT252 line contain three small chromosomes, of 300, 350 and 385 kb. Quantitative densitometry of ethidium bromide-stained gels suggest that these chromosomes are present in equal levels (2:2:2). Two derivatives of this line, one appearing spontaneously (LT252 delta) and one obtained following selection with methotrexate (11-MTXR20), exhibit altered levels of these chromosomes, in the ratio of 2:1:3, respectively. The variant pattern in both lines is due to an increase in size of chromosome 2, yielding a new chromosome similar in size to chromosome 3. The enlarged chromosome 2 of the LT252 delta line is a result of amplification of the mini-exon gene array normally located on this chromosome, which increases from about 93 to 150 copies of the 0.44-kb mini-exon tandem repeat, as shown by quantitative hybridization and sizing of the mini-exon array. In contrast, the increased size of chromosome 2 within the methotrexate-resistant mutant 11-MTXR20 is not due to mini-exon amplification. In both variant lines, there are equal levels of the wild-type and enlarged chromosome 2, and the wild-type chromosome 2 is now present at 50% of the level of chromosome 1. These and other data suggest that Leishmania is diploid for chromosomes bearing housekeeping genes such as the mini-exon locus.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2710169     DOI: 10.1016/0166-6851(89)90009-1

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  15 in total

1.  A physical map of the Leishmania major Friedlin genome.

Authors:  A C Ivens; S M Lewis; A Bagherzadeh; L Zhang; H M Chan; D F Smith
Journal:  Genome Res       Date:  1998-02       Impact factor: 9.043

2.  Genomic variation of Trypanosoma cruzi: involvement of multicopy genes.

Authors:  W Wagner; M So
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

3.  The Leishmania genome comprises 36 chromosomes conserved across widely divergent human pathogenic species.

Authors:  P Wincker; C Ravel; C Blaineau; M Pages; Y Jauffret; J P Dedet; P Bastien
Journal:  Nucleic Acids Res       Date:  1996-05-01       Impact factor: 16.971

4.  Double targeted gene replacement for creating null mutants.

Authors:  A Cruz; C M Coburn; S M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

Review 5.  Leishmaniases of the New World: current concepts and implications for future research.

Authors:  G Grimaldi; R B Tesh
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

6.  Plasticity in chromosome number and testing of essential genes in Leishmania by targeting.

Authors:  A K Cruz; R Titus; S M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

7.  A new non-LTR retrotransposon provides evidence for multiple distinct site-specific elements in Crithidia fasciculata miniexon arrays.

Authors:  S C Teng; S X Wang; A Gabriel
Journal:  Nucleic Acids Res       Date:  1995-08-11       Impact factor: 16.971

8.  Co-existence of circular and multiple linear amplicons in methotrexate-resistant Leishmania.

Authors:  A Olmo; R Arrebola; V Bernier; D González-Pacanowska; L M Ruiz-Pérez
Journal:  Nucleic Acids Res       Date:  1995-08-11       Impact factor: 16.971

9.  Unstable amplification of two extrachromosomal elements in alpha-difluoromethylornithine-resistant Leishmania donovani.

Authors:  S Hanson; S M Beverley; W Wagner; B Ullman
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

10.  Genomic variation in Trypanosoma cruzi clonal cultures.

Authors:  A M Alves; D F de Almeida; W M von Krüger
Journal:  Parasitol Res       Date:  1996       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.